10.1016/j.tifs.2018.04.010 [DOI] [PMC free article] [PubMed] [Google Scholar] Stephens, N
One such substance, LY3437943, has been discovered to exhibit vigorous agonist activity on three distinct receptors, including the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors
PubMed CrossRef Vidarsdottir S, de Leeuw van Weenen JE, Frlich M, et al
The GLP-1 research reinforces the value of this comprehensive model and opens new possibilities for the role that medication-assisted approaches can play in individualized treatment plans
Other compounding pharmacies were not using the exact same form of semaglutide as the brand-name drugs, instead using cheaper research grade, food grade, and/or different salt forms